TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

Go back to TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
TG THERAP (NASDAQ: TGTX) Delayed: 54.34 -1.4 (2.51%)
Previous Close $55.74    52 Week High $14.87 
Open $55.55    52 Week Low $4.90 
Day High $57.14    P/E N/A 
Day Low $54.24    EPS $-0.67 
Volume 564,541